Endothelial ADAM10 controls cellular response to oxLDL and its deficiency exacerbates atherosclerosis with intraplaque hemorrhage and neovascularization in mice

E.P.C. van der Vorst, S.L. Maas*, K. Theodorou, L.J.F. Peters, H. Jin, T. Rademakers, M.J. Gijbels, M. Rousch, Y. Jansen, C. Weber, M. Lehrke, C. Lebherz, D. Yildiz, A. Ludwig, J.F. Bentzon, E.A.L. Biessen, M.M.P.C. Donners*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


IntroductionThe transmembrane protease A Disintegrin And Metalloproteinase 10 (ADAM10) displays a "pattern regulatory function," by cleaving a range of membrane-bound proteins. In endothelium, it regulates barrier function, leukocyte recruitment and angiogenesis. Previously, we showed that ADAM10 is expressed in human atherosclerotic plaques and associated with neovascularization. In this study, we aimed to determine the causal relevance of endothelial ADAM10 in murine atherosclerosis development in vivo. Methods and resultsEndothelial Adam10 deficiency (Adam10(ecko)) in Western-type diet (WTD) fed mice rendered atherogenic by adeno-associated virus-mediated PCSK9 overexpression showed markedly increased atherosclerotic lesion formation. Additionally, Adam10 deficiency was associated with an increased necrotic core and concomitant reduction in plaque macrophage content. Strikingly, while intraplaque hemorrhage and neovascularization are rarely observed in aortic roots of atherosclerotic mice after 12 weeks of WTD feeding, a majority of plaques in both brachiocephalic artery and aortic root of Adam10(ecko) mice contained these features, suggestive of major plaque destabilization. In vitro, ADAM10 knockdown in human coronary artery endothelial cells (HCAECs) blunted the shedding of lectin-like oxidized LDL (oxLDL) receptor-1 (LOX-1) and increased endothelial inflammatory responses to oxLDL as witnessed by upregulated ICAM-1, VCAM-1, CCL5, and CXCL1 expression (which was diminished when LOX-1 was silenced) as well as activation of pro-inflammatory signaling pathways. LOX-1 shedding appeared also reduced in vivo, as soluble LOX-1 levels in plasma of Adam10(ecko) mice was significantly reduced compared to wildtypes. DiscussionCollectively, these results demonstrate that endothelial ADAM10 is atheroprotective, most likely by limiting oxLDL-induced inflammation besides its known role in pathological neovascularization. Our findings create novel opportunities to develop therapeutics targeting atherosclerotic plaque progression and stability, but at the same time warrant caution when considering to use ADAM10 inhibitors for therapy in other diseases.
Original languageEnglish
Article number974918
Number of pages13
JournalFrontiers in Cardiovascular Medicine
Issue number1
Publication statusPublished - 27 Jan 2023


  • a disintegrin and metalloproteinase 10
  • atherosclerosis
  • endothelial cells
  • intraplaque hemorrhage
  • neovascularization
  • inflammatory signaling
  • LOX-1
  • GENE


Dive into the research topics of 'Endothelial ADAM10 controls cellular response to oxLDL and its deficiency exacerbates atherosclerosis with intraplaque hemorrhage and neovascularization in mice'. Together they form a unique fingerprint.

Cite this